Foxy, a designer tryptamine hallucinogen

Journal of Analytical Toxicology

Volumn 27, Issue 5, 2003, Pages 313-317

  Meatherall, Robert ^a   Sharma, Pankaj ^b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b Victoria General Hospital Winnipeg   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHOXY INDOLEACETIC ACID; 5 METHOXY N ISOPROPYLTRYPTAMINE; 5 METHOXY N,N DIISOPROPYLTRYPTAMINE N' OXIDE; DRUG METABOLITE; N,N DIISOPROPYL 5 METHOXYTRYPTAMINE; PSYCHEDELIC AGENT; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; CONFERENCE PAPER; DEAMINATION; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; EUPHORIA; FOLLOW UP; GAS CHROMATOGRAPHY; HALLUCINATION; HUMAN; LIMB; MALE; MASS SPECTROMETRY; PARALYSIS; PILL; QUANTITATIVE ANALYSIS; URINALYSIS;

EUPHORIA;

EID: 0037623901     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/27.5.313     Document Type: Conference Paper

References (23)

1. U.S. Drug Enforcement Administration. Microgram Bull. 34(6): 126 (2001).
2. U.S. Drug Enforcement Administration. Microgram Bull. 34(8): 193 (2001).
3. U.S. Drug Enforcement Administration. Microgram Bull. 34(10): 263 (2001).
4. U.S. Drug Enforcement Administration. Microgram Bull. 35(4): 96 (2002).
5. U.S. Drug Enforcement Administration. Microgram Bull. 35(5): 122 (2002).
6. J. Faulkner. 5-Methoxy-di-isopropyltryptamine tablets identified. J. Clandestine Lab. Invest. Chem. 12: 13 (2002).
7. A.T. Shulgin and M.F. Carter. N,N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), two orally active tryptamine analogs with CNS activity. Commun. Psychopharmacol. 4: 363-369 (1980).
8. A. Shulgin and A. Shulgin. TINKAL (Tryptamines I Have Known and Loved) the Continuation. Transform Press, Berkeley, CA, 1997, pp 527-531.
9. E.H. Foerster, D. Hatchett, and J.C. Garriott. A rapid comprehensive screening procedure for basic drugs in blood or tissues by gas chromatography. J. Anal. Toxicol. 2: 50-55 (1978).
10. R. Meatherall. GC/MS confirmation of barbiturates in blood and urine. J. Forensic Sci. 42: 1160-1170 (1997).
11. R.M. Anthony, C.A. Sutheimer, and I. Sunshine. Acetaldehyde, methanol and ethanol analysis by headspace gas chromatography. J. Anal. Toxicol. 4: 43-45 (1980).
12. N.C. Jain. Direct blood-injection method for gas chromatographic determination of alcohols and other volatile compounds. Clin. Chem. 17: 82-85 (1971).
13. 9-carboxy-tetrahydrocannabinol in urine with the Finnigan ITS40. J. Anal. Toxicol. 14: 292-295 (1990).
14. R. Meatherall. GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine. J. Anal. Toxicol. 23: 177-186 (1999).
15. R. Meatherall and D. Ford. Isocratic liquid chromatographic determination of theophylline, acetaminophen, chloramphenicol, caffeine, anticonvulsants and barbiturates in serum. Ther. Drug Monit. 10: 101-115 (1988).
16. R. Meatherall. Rapid GC-MS confirmation of urinary amphetamine and methamphetamine as their propylchloroformate derivatives. J. Anal. Toxicol. 19: 316-322 (1995).
17. B.R. Sitaram and W.R. McLeod. Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies. Biol. Psychiatry 28: 841-848 (1990).
18. S.A. Barker, J.M. Beaton, S.T. Christian, J.A. Monti, and P.E. Morris. In vivo metabolism of tetradeutero N,N′-dimethyltryptamine in rodent brain. Biochem. Pharmacol. 33: 1395-1400 (1984).
19. 14 in the rat. Biochem. Pharmacol. 18: 2771-2781 (1969).
20. B.R. Sitaram, L. Lockett, G.L. Blackman, and W.R. McLeod. Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat. Biochem. Pharmacol. 36: 2235-2237 (1987).
21. R.A. Morano, C. Speis, F.B. Walker, and S.M. Plank. Fatal intoxication involving tryptamine. J. Forensic Sci. 38: 721-725 (1993).
22. S.C. Chattorai and N.B. Watts. Endocrinology. In Textbook of Clinical Chemistry, N.W. Tietz, Ed. W.B. Saunders, Philadelphia, PA, 1986, p 1159.
23. N.S. Buckholtz and W.O. Boggan. Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure activity relationships and substrate specificity. Biochem. Pharmacol. 26: 1991-1996 (1977).